Factsheet – How the European Commission works on Rare Diseases and the European Reference Networks (ERNs)

Overview of the European Commission’s coordinated approach to rare diseases, including policy, research, and the role of European Reference Networks.

This factsheet outlines how the European Commission supports action on rare diseases through policy frameworks, research funding, and collaboration across Member States. It explains the role of European Reference Networks (ERNs) as cross-border networks connecting specialised centres to address rare and complex conditions, and highlights initiatives related to orphan medicines, medical devices, and data sharing, including the European Health Data Space.

Acces this publication
Factsheet – How the European Commission works on Rare Diseases and the European Reference Networks (ERNs)

Year of publication

2026

Source

European Commission – Directorate-General for Health and Food Safety

Author

Directorate-General for Health and Food Safety (European Commission)

You might also be interested in

Irish Presidency of the EU in 2026

Why Rare Diseases Matter for Europe’s Future Embedding Research and Innovation as Standard of Care in Rare Disease

October 2 @ 10:00 am - 5:15 pm
On 13 November 2026 in Dublin, Ireland, this event will explore how research, innovation, patient partnership and EU policy can improve rare disease care and strengthen Europe’s life sciences ecosystem.
European Medicines Agency (EMA)

EMA launches a new pilot to advance innovative methods to animal testing

The voluntary data submission framework allows developers to share data generated using New Approach Methodologies outside marketing authorisation applications and receive tailored, non-binding feedback from European regulatory experts.
ERDERA Knowledge Exchange Meeting

ERDERA Knowledge Exchange Meeting on Drug Repurposing for Rare Diseases

November 25 - November 26
Discover practical pathways to repurpose medicines for rare diseases, exchange experiences and best practices between underrepresented and high-performing countries, and build new partnerships at the ERDERA Knowledge Exchange Meeting in Riga on 25-26 November.
ERDERA clinical trial call

ERDERA Clinical Trial Call – Annex IV. Guidelines for Canadian Applicants

This annex explains the specific eligibility, sponsorship, funding and application requirements for Canadian applicants in the ERDERA Clinical Trial Call.

ERDERA Search